Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 1993-01-01 (33 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CANET-EN-ROUSSILLON (66140), Pyrenees-Orientales
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE BOBO DURAND : revenue, balance sheet and financial ratios
PHARMACIE BOBO DURAND is a French company
founded 33 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CANET-EN-ROUSSILLON (66140),
this company of category PME
shows in 2024 a net income positive of 202 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE BOBO DURAND (SIREN 392070710)
Indicator
2024
2023
Revenue
N/C
N/C
Net income
202 164 €
67 092 €
EBITDA
N/C
N/C
Net margin
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE BOBO DURAND generates positive net income of 202 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2023-2024: 67 k€ -> 202 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
202 164 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 58%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 34%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
58.095%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
34.326%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2023
2024
Debt ratio
113.457
58.095
Financial autonomy
23.644
34.326
Repayment capacity
None
None
Cash flow / Revenue
None%
None%
Sector positioning
Debt ratio
58.092024
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good-12 pts over 2 years
In 2024, the debt ratio of PHARMACIE BOBO DURAND (58.09) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
34.33%2024
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+6 pts over 2 years
In 2024, the financial autonomy of PHARMACIE BOBO DURAND (34.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 123.77. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2023
2024
Liquidity ratio
111.305
123.765
Interest coverage
None
None
Sector positioning
Liquidity ratio
123.772024
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Watch
In 2024, the liquidity ratio of PHARMACIE BOBO DURAND (123.77) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE BOBO DURAND in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE BOBO DURAND is estimated at
2 822 358 €
(range 1 965 446€ - 4 222 410€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1965k€2822k€4222k€
2 822 358 €Range: 1 965 446€ - 4 222 410€
NAF 5 année 2024
Valuation method used
Net Income Multiple
202 164 €
×
14.0x
=2 822 359 €
Range: 1 965 446€ - 4 222 410€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE BOBO DURAND with other companies in the same sector:
Frequently asked questions about PHARMACIE BOBO DURAND
What is the revenue of PHARMACIE BOBO DURAND ?
The revenue of PHARMACIE BOBO DURAND is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE BOBO DURAND profitable?
Yes, PHARMACIE BOBO DURAND generated a net profit of 202 k€ in 2024.
Where is the headquarters of PHARMACIE BOBO DURAND ?
The headquarters of PHARMACIE BOBO DURAND is located in CANET-EN-ROUSSILLON (66140), in the department Pyrenees-Orientales.
Where to find the tax return of PHARMACIE BOBO DURAND ?
The tax return of PHARMACIE BOBO DURAND is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE BOBO DURAND operate?
PHARMACIE BOBO DURAND operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart